138 related articles for article (PubMed ID: 1625614)
1. Mild bleeding disorders. A clinical and laboratory study.
Parkin JD; Smith IL; O'Neill AI; Ibrahim KM; Butcher LA
Med J Aust; 1992 May; 156(9):614-7. PubMed ID: 1625614
[TBL] [Abstract][Full Text] [Related]
2. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the O'Brien filter test and the PFA-100 platelet analyzer in the laboratory diagnosis of von Willebrand's disease.
Schlammadinger A; Kerenyi A; Muszbek L; Boda Z
Thromb Haemost; 2000 Jul; 84(1):88-92. PubMed ID: 10928476
[TBL] [Abstract][Full Text] [Related]
4. Bleeding disorders in teenagers presenting with menorrhagia.
Jayasinghe Y; Moore P; Donath S; Campbell J; Monagle P; Grover S
Aust N Z J Obstet Gynaecol; 2005 Oct; 45(5):439-43. PubMed ID: 16171484
[TBL] [Abstract][Full Text] [Related]
5. Predictors of bleeding disorders in children with epistaxis: value of preoperative tests and clinical screening.
Elden L; Reinders M; Witmer C
Int J Pediatr Otorhinolaryngol; 2012 Jun; 76(6):767-71. PubMed ID: 22459034
[TBL] [Abstract][Full Text] [Related]
6. [Von Willebrand's disease in the IX Region of Chile].
Cabrera ME; Artigas CG; Páez E; Monsalve V; Zolezzi P; Arauco G; Espinoza R; Hevia C; Villegas J
Rev Med Chil; 1989 Apr; 117(4):423-30. PubMed ID: 2519397
[TBL] [Abstract][Full Text] [Related]
7. [Recurrent epistaxis in children as an indicator of hemostatic disorders].
García Callejo FJ; Velert Vila MM; Marco Algarra J
An Esp Pediatr; 1998 Nov; 49(5):475-80. PubMed ID: 9949588
[TBL] [Abstract][Full Text] [Related]
8. Laboratory issues in bleeding disorders.
Lillicrap D; Nair SC; Srivastava A; Rodeghiero F; Pabinger I; Federici AB
Haemophilia; 2006 Jul; 12 Suppl 3():68-75. PubMed ID: 16683999
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of abnormal bleeding in women.
Kouides PA
Curr Hematol Rep; 2002 Sep; 1(1):11-8. PubMed ID: 12901120
[TBL] [Abstract][Full Text] [Related]
10. Screening for coagulation disorders in adolescents with abnormal uterine bleeding.
Kulp JL; Mwangi CN; Loveless M
J Pediatr Adolesc Gynecol; 2008 Feb; 21(1):27-30. PubMed ID: 18312797
[TBL] [Abstract][Full Text] [Related]
11. On the value of menorrhagia as a predictor for coagulation disorders.
Edlund M; Blombäck M; von Schoultz B; Andersson O
Am J Hematol; 1996 Dec; 53(4):234-8. PubMed ID: 8948660
[TBL] [Abstract][Full Text] [Related]
12. [Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis].
Thommen D; Sulzer I; Buhrfeind E; Naef R; Furlan M; Lämmle B
Schweiz Med Wochenschr; 1988 Oct; 118(43):1559-67. PubMed ID: 3238391
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic assessment of platelet disorders: what are the challenges to standardization?
Pai M; Hayward CP
Semin Thromb Hemost; 2009 Mar; 35(2):131-8. PubMed ID: 19408186
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of disorders of haemostasis in adolescents with menorrhagia referred to a haemophilia treatment centre.
Mikhail S; Varadarajan R; Kouides P
Haemophilia; 2007 Sep; 13(5):627-32. PubMed ID: 17880454
[TBL] [Abstract][Full Text] [Related]
15. A critical reappraisal of the bleeding time.
Rodgers RP; Levin J
Semin Thromb Hemost; 1990 Jan; 16(1):1-20. PubMed ID: 2406907
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
[TBL] [Abstract][Full Text] [Related]
17. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible.
Pereira J; Quiroga T; Mezzano D
Semin Thromb Hemost; 2008 Oct; 34(7):654-62. PubMed ID: 19085766
[TBL] [Abstract][Full Text] [Related]
18. The usefulness of the platelet function analyser (PFA-100) in screening for underlying bleeding disorders in women with menorrhagia.
Acharya S; Barraclough J; Ibrahim MS; Oxby C; Jones SE; Parapia L; O'donovan P
J Obstet Gynaecol; 2008 Apr; 28(3):310-4. PubMed ID: 18569475
[TBL] [Abstract][Full Text] [Related]
19. A reassessment of the bleeding time: association of age, hematocrit, platelet function, von Willebrand factor, and bleeding time thromboxane B2 with the length of the bleeding time.
Gerrard JM; Docherty JC; Israels SJ; Cheang MS; Bishop AJ; Kobrinsky NL; Schroeder ML; Israels ED
Clin Invest Med; 1989 Jun; 12(3):165-71. PubMed ID: 2787219
[TBL] [Abstract][Full Text] [Related]
20. Menorrhagia and bleeding disorders.
El-Hemaidi I; Gharaibeh A; Shehata H
Curr Opin Obstet Gynecol; 2007 Dec; 19(6):513-20. PubMed ID: 18007127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
